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• Tuberculosis (TB) is an ancient highly contagious 
bacterial disease caused by a bacterium called 
Mycobacterium tuberculosis.
• TB bacteria are released into the air when a person 
infected with TB disease of the lungs or throat 
spreads the bacteria by coughing, sneezing, 
speaking, or singing.
• Two TB conditions exist: 
TB disease and Latent TB infection (LTBI) 
• When active, the bacteria typically attack the lungs 
but can attack any part of the body including the 
brain, spine, and kidney.
• TB disease cases remain costly and resource 
demanding for Health Care Systems. 
• The purpose of our study is to review TB disease 
cases from 2014-July 2019, managed by the 
Allentown Health Bureau, to learn new knowledge 
that could apply to our Lehigh Valley practitioners to 
improve early detection of TB disease.
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• 16 cases of TB disease from 2014-2018 and 1 case of 
TB disease that completed treatment in July 2019, 
managed at the Allentown Health Bureau (AHB), 
were included in this study for review.
• Paper and electronic charts were reviewed and 
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Epidemiology at Time of Diagnosis
• Age: 59 years old (28-89 years old)
• Male: 82%
• Female: 18%
• Non-US Born: 88%
• US Born: 12%
• Time Residing in US : 26 years (2-72 years)
Presentation
• Pulmonary TB: 88%
• Fever: 59%
• Cough: 47%  (NO Cough 53%)
• Length of Cough: 37 days (3-112 days)
• Weight Loss: 53%
• NO Known Exposure: 82%
• NO Abnormal Labs: 65%
• Abnormal Labs Anemia: 23%
Diagnosis
• NO Purified Protein Derivative (PPD) Done: 88%
• QuantiFERON-TB Test: 82% (14 patients) 
• QuantiFERON-TB Test Positive: 100% (14 patients)
• HIV (Human Immunodeficiency Virus)
Negative: 15 (88%) Positive: 1 (12%)
• Able to Produce Sputum: 82%
• Positive Sputum Smear(s): 57%
• Chest X-Ray Done: 100%
• Abnormal Chest X-Ray: 94% (Upper lobes 88%)
• Abnormal Chest CT Scan: 94% (1 not done)
Treatment
• Sensitive to RIPE: 88%
• 1 (12%) Resistant to Isoniazid (INH) and 
Pyrazinamide (PZA) 
• Standard Treatment (6-9mo): 88% (15 patients)
• Extended Treatment (>9mo): 12% (2 patients)
Results Continued
**The average price of the treatment cost for TB disease per patient was based on 
Health Network Labs (HNL)/Lehigh Valley Physicians Group (LVPG)/Medicare 
charges.
** Two patient had prolonged inpatient stays that affected the average.
**Additional fees were not included for imaging, procedures, and physician rounds.
• TB disease is still active in Allentown, PA
• TB presentation and epidemiology is changing 
toward non-US born patients
• TB disease management remains very costly and
resource demanding
• Future: early diagnosis/treatment of TB disease & 
LTBI will greatly reduce the cost of TB management
6 •Estimated Cost
Patient Contacts
• Number of Contacts Evaluated: median 7 (0-78)
Estimated Cost of TB disease
•**Average ESTIMATE: $91,793.15
•**Median ESTIMATE: $44,976.15
•**Range: $1,383.89-$365,486.90
